Form 8-K - Current report:
SEC Accession No. 0001193125-25-024518
Filing Date
2025-02-12
Accepted
2025-02-11 20:46:03
Documents
20
Period of Report
2025-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d862672d8k.htm   iXBRL 8-K 36149
2 EX-1.1 d862672dex11.htm EX-1.1 220505
3 EX-4.1 d862672dex41.htm EX-4.1 71481
4 EX-5.1 d862672dex51.htm EX-5.1 13620
5 EX-99.1 d862672dex991.htm EX-99.1 9421
6 EX-99.2 d862672dex992.htm EX-99.2 10069
10 GRAPHIC g862672g0211234818769.jpg GRAPHIC 2720
11 GRAPHIC g862672g0211234818935.jpg GRAPHIC 1548
  Complete submission text file 0001193125-25-024518.txt   593113

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sera-20250210.xsd EX-101.SCH 2862
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sera-20250210_lab.xml EX-101.LAB 18737
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sera-20250210_pre.xml EX-101.PRE 11715
22 EXTRACTED XBRL INSTANCE DOCUMENT d862672d8k_htm.xml XML 3789
Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Filer) CIK: 0001534969 (see all company filings)

EIN.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40606 | Film No.: 25611580
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)